glucagon has been researched along with Polycystic Ovary Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Cedillo, YE; Chandler-Laney, PC; Deemer, SE; Goss, AM; Gower, BA; Hoover, SE | 1 |
| Broughton, KS; LeMieux, MJ; Rao, M; Zumbro, EL | 1 |
| Bergman, RN; Dunaif, A; Sam, S; Vellanki, P; Yalamanchi, SK | 1 |
| Bendlová, B; Dvoráková, K; Hill, M; Stanická, S; Stárka, L; Vondra, K; Vrbíková, J | 1 |
| Byström, B; Hirschberg, AL; Holtet, J; Naessén, S; Stridsberg, M | 1 |
| Durlach, V; Gross, A; Grulet, H; Hecart, AC; Leutenegger, M | 1 |
| Birkenhäger, JC; Docter, R; Fauser, BC; Jacobs, ML; Loriaux, DL; Pache, TD; Weber, RF | 1 |
| Gama, R; Hampton, S; Marks, V; Morgan, L; Norris, F; Watkins, S; Wright, J | 1 |
| Apa, R; Caruso, A; Ciampelli, M; Cucinelli, F; Fulghesu, AM; Guido, M; Lanzone, A; Murgia, F | 1 |
| Belosi, C; Cento, R; Ciampelli, M; Fortini, A; Fulghesu, AM; Guido, M; Lanzone, A; Murgia, F; Muzj, G | 1 |
| Elstein, M; Golland, IM; Laing, I; Shalet, SM; Vaughan Williams, CA | 1 |
3 trial(s) available for glucagon and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS.
Topics: Adult; Cross-Over Studies; Diet; Energy Intake; Female; Follow-Up Studies; Ghrelin; Glucagon; Glycemic Load; Humans; Hunger; Male; Middle Aged; Polycystic Ovary Syndrome; Prognosis; Satiety Response; Young Adult | 2021 |
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Analysis of Variance; Blood Glucose; Contraceptive Agents; Cyproterone Acetate; Drug Combinations; Estradiol; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Polycystic Ovary Syndrome | 2004 |
Acute insulin response to intravenous glucagon in polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Female; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Obesity; Polycystic Ovary Syndrome | 1998 |
8 other study(ies) available for glucagon and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Whey protein preload enhances the active GLP-1 response and reduces circulating glucose in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Analysis of Variance; Area Under Curve; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Dietary Supplements; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Hyperglycemia; Incretins; Insulin; Polycystic Ovary Syndrome; Postprandial Period; Whey Proteins; Young Adult | 2021 |
Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Mass Index; Female; Glucagon; Glucose Clamp Technique; Hormones; Humans; Hypoglycemia; Insulin; Obesity; Polycystic Ovary Syndrome; Postmenopause | 2017 |
Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome.
Topics: Adult; Appetite Regulation; Blood Glucose; Body Mass Index; Bulimia; C-Peptide; Cholecystokinin; Female; Food; Food Preferences; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Polycystic Ovary Syndrome; Satiation; Sex Hormone-Binding Globulin; Testosterone | 2004 |
Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Hypertension; Insulin; Insulin Resistance; Male; Norepinephrine; Obesity; Polycystic Ovary Syndrome; Reference Values; Sex Factors | 1993 |
The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Islets of Langerhans; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1993 |
The entero-insular axis in polycystic ovarian syndrome.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Neurotransmitter Agents; Peptide Fragments; Polycystic Ovary Syndrome; Proinsulin | 1996 |
Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus.
Topics: Administration, Oral; Adolescent; Adult; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Narcotic Antagonists; Polycystic Ovary Syndrome | 1998 |
Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.
Topics: Adult; Androgens; Androstenedione; Blood Glucose; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1990 |